1Gilmour LM,Macleod KG,McCaig A,et al.Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer.Cancer Res,2001,61(5):2169-2176
2Ellerbroek SM,Halbleib JM,Benavidez M,et al.Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.Cancer Res,2001,61 (5):1855-1861
3Alper O,Bergmann-Leitner ES,Bennett TA,et al.Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.J Natl Cancer Inst,2001,93(18):1375-1384
4Sewell JM,Macleod KG,Ritchie A,et al.Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839("Iressa").Br J Cancer,2002,86(3):456-462
5Hwang MS,Yum YN,Joo JH,et al.Inhibition of c-erbB-2 expression an activity in human ovarian carcinoma cells by hypericin.Anticancer Res,2001,21 (4A):2649-2655
6Fujimoto J,Sakaguchi H,Hirose R,et al.Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma.Cancer,1999,83(12):2528-2533
7Carzetti GG,Ciavattini A,Lucarini G,et al.Expression of vascular endothelial growth factor related to 72-kolodalton metallo-proteinase immunostaining in patients with serious ovarian carcinoma.Cancer,1999,85(10):2219-2225
8Li D,Williams JI,Pietras RJ.Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.Oncogene,2002,21(18):2805-2814
9Ueoka Y,Kato K,Kuriaki Y,et al.Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway.Br J Cancer,2000,82(4):891-899
10Grundker C,Volker P,Emons G.Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha (I)-mediated activation of phosphotyrosine phosphatase.Endocrinology,2001,142(6):2369-2380
